The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 4, 2011, Pages 927-931

  Parent, Brodie ^a   Awan, Nasir ^a   Berman, Sarah B ^a   Suski, Valerie ^a   Moore, Robert ^a   Crammond, Donald ^a   Kondziolka, Douglas ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Age; Deep brain stimulation; Disease duration; Parkinson disease

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONFUSION; CONTROLLED STUDY; DEVICE INFECTION; DEVICE REMOVAL; DISEASE DURATION; DYSKINESIA; EVOKED MUSCLE RESPONSE; FEMALE; FOCAL EPILEPSY; GROUPS BY AGE; HUMAN; MALE; MUSCLE RIGIDITY; PARKINSON DISEASE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; SUBTHALAMIC NUCLEUS BRAIN DEPTH STIMULATION; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

AGE FACTORS; AGE OF ONSET; AGED; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; PATIENT SELECTION; QUALITY OF LIFE; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 79953681063     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.10.JNS10756     Document Type: Article

References (16)

1. Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G, et al: Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 59:932-934, 2002
2. Defer GL, Widner H, Marié RM, Rémy P, Levivier M: Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 14:572-584, 1999 (Pubitemid 30011449)
3. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355:896-908, 2006 (Pubitemid 44315982)
4. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21 (Suppl 14):S290-S304, 2006 (Pubitemid 44028288)
5. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, et al: Deep brain stimulation: preoperative issues. Mov Disord 21 (Suppl 14):S171-S196, 2006 (Pubitemid 44028281)
6. Marconi R, Landi A, Valzania F: Subthalamic nucleus stimulation in Parkinson's disease. Neurol Sci 29 (Suppl 5):S389-S391, 2008
7. Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ, Martin-Linares JM, Meersmans M, Ortega-Moreno A, et al: Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry 76:34-39, 2005 (Pubitemid 40013488)
8. Moro E, Allert N, Eleopra R, Houeto JL, Phan TM, Stoevelaar H: A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease. J Neurol 256:83-88, 2009
9. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738-750, 2003
10. Rodriguez RL, Fernandez HH, Haq I, Okun MS: Pearls in patient selection for deep brain stimulation. Neurologist 13:253-260, 2007 (Pubitemid 47396311)
11. Schüpbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, Welter ML, et al: Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 68:267-271, 2007 (Pubitemid 46148337)
12. Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, et al: Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects. Stereotact Funct Neurosurg 87:241-248, 2009
13. Volkmann J: Deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 13 (Suppl 3):S462-S465, 2007
14. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301:63-73, 2009
15. Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, et al: Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 125:575-583, 2002 (Pubitemid 34194412)
16. Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, et al: Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 25:702-708, 2010